Evidence map›Paper›PMID 35675330›Full record

ArticlePLoS genetics2022

Identification of Arhgef12 and Prkci as genetic modifiers of retinal dysplasia in the Crb1rd8 mouse model.

Sonia M Weatherly, Gayle B Collin, Jeremy R Charette, Lisa Stone, Nattaya Damkham, Lillian F Hyde, James G Peterson, Wanda Hicks, Gregory W Carter, Jürgen K Naggert and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Variant-to-gene mapping identifiesbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Development of Retinal Astroglia.Annual review of vision science · 2025
    Review
  5. Review
  6. Pigmented paravenous chorioretinal atrophy: Updated scenario.European journal of ophthalmology · 2024
    Review
  7. Article
  8. Article
  9. A mouse model of cone photoreceptor function lossFrontiers in molecular neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Sonia M WeatherlyThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Gayle B CollinThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-3332-0954
Jeremy R CharetteThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Lisa StoneThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-3998-9579
Nattaya DamkhamThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-7359-8547
Lillian F HydeThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0001-6230-4630
James G PetersonThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0001-6126-2993
Wanda HicksThe Jackson Laboratory, Bar Harbor, Maine, United States of America.
Gregory W CarterThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0002-2834-8186
Jürgen K NaggertThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0001-8213-0869
Mark P KrebsThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0001-9017-6066
Patsy M NishinaThe Jackson Laboratory, Bar Harbor, Maine, United States of America.ORCID 0000-0003-1640-5945
Jackson Laboratory · USSiriraj Hospital · TH

Funding

The IU/JAX Alzheimer's Disease Precision Models Center: Rat F344U54AG054345 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI Gareth R Howell · 2016 to 2026
$95.6M
TREAT AD Structural Biology CoreU54AG065187 · NIA · EMORY UNIVERSITY · PI Gregory W Carter, ALLAN I LEVEY · 2019 to 2026
$69.7M
Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Paul Robson · 1985 to 2026
$61.9M
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGYR01EY011996 · NEI · JACKSON LABORATORY · PI Patsy M Nishina · 1998 to 2026
$12.4M
Genetic Modifiers of Retinal DiseaseR01EY027305 · NEI · JACKSON LABORATORY · PI Patsy M Nishina · 2017 to 2026
$5.2M
Identifying Shared Pathogenic Networks and Molecular Targets Underlying Retinal Pigmented Epithelial Associated DiseaseR01EY027860 · NEI · JACKSON LABORATORY · PI CARTER, GREGORY W, NISHINA, PATSY M · 2017 to 2020
$2.4M
Genetic Modifiers of Enhanced S-cone Syndrome –Role of the External Limiting MembraneR01EY028561 · NEI · JACKSON LABORATORY · PI NAGGERT, JUERGEN K. · 2018 to 2022
$2.2M
NCI NIH HHS P30 CA034196NEI NIH HHS R01 EY011996NEI NIH HHS R01 EY027305NEI NIH HHS R01 EY027860NEI NIH HHS R01 EY028561NIA NIH HHS U54 AG054345NIA NIH HHS U54 AG065187
6 · The paper itself

Abstract

Mutations in the apicobasal polarity gene CRB1 lead to diverse retinal diseases, such as Leber congenital amaurosis, cone-rod dystrophy, retinitis pigmentosa (with and without Coats-like vasculopathy), foveal retinoschisis, macular dystrophy, and pigmented paravenous chorioretinal atrophy. Limited correlation between disease phenotypes and CRB1 alleles, and evidence that patients sharing the same alleles often present with different disease features, suggest that genetic modifiers contribute to clinical variation. Similarly, the retinal phenotype of mice bearing the Crb1 retinal degeneration 8 (rd8) allele varies with genetic background. Here, we initiated a sensitized chemical mutagenesis screen in B6.Cg-Crb1rd8/Pjn, a strain with a mild clinical presentation, to identify genetic modifiers that cause a more severe disease phenotype. Two models from this screen, Tvrm266 and Tvrm323, exhibited increased retinal dysplasia. Genetic mapping with high-throughput exome and candidate-gene sequencing identified causative mutations in Arhgef12 and Prkci, respectively. Epistasis analysis of both strains indicated that the increased dysplastic phenotype required homozygosity of the Crb1rd8 allele. Retinal dysplastic lesions in Tvrm266 mice were smaller and caused less photoreceptor degeneration than those in Tvrm323 mice, which developed an early, large diffuse lesion phenotype. At one month of age, Müller glia and microglia mislocalization at dysplastic lesions in both modifier strains was similar to that in B6.Cg-Crb1rd8/Pjn mice but photoreceptor cell mislocalization was more extensive. External limiting membrane disruption was comparable in Tvrm266 and B6.Cg-Crb1rd8/Pjn mice but milder in Tvrm323 mice. Immunohistological analysis of mice at postnatal day 0 indicated a normal distribution of mitotic cells in Tvrm266 and Tvrm323 mice, suggesting normal early development. Aberrant electroretinography responses were observed in both models but functional decline was significant only in Tvrm323 mice. These results identify Arhgef12 and Prkci as modifier genes that differentially shape Crb1-associated retinal disease, which may be relevant to understanding clinical variability and underlying disease mechanisms in humans.

Indexed as

Nerve Tissue ProteinsRetinal DysplasiaRho Guanine Nucleotide Exchange FactorsAnimalsDisease Models, AnimalEye ProteinsIsoenzymesMembrane ProteinsMiceMice, Inbred C57BLMutationProtein Kinase CProtein Kinase C-lambdaRetinaRetinal DegenerationArhgef12 protein, mouseCrb1 protein, mouseEye ProteinsIsoenzymesMembrane ProteinsNerve Tissue ProteinsProtein Kinase CProtein Kinase C-lambdaRho Guanine Nucleotide Exchange Factors

Identifiers

PMID35675330
PMCPMC9212170
OpenAlexW4282939440

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.